Leverette

Ethinylestradiol and Levonorgestrel, the active ingredients in Leverette, are a combined oral contraceptive presented as tablets for oral use. They are prescribed to prevent pregnancy and to regulate menstrual cycles in women of reproductive age, and may also be used to manage menstrual disorders under medical supervision.

GNH USA supplies Leverette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global distribution. Our supply chain adheres to stringent temperature and humidity controls, and we provide full regulatory documentation to support import and clinical use.

Leverette, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy. - Contraception: Prevents ovulation and thereby avoids pregnancy in women of reproductive age. - Menstrual cycle regulation: Helps establish regular menstrual bleeding patterns. - Acne management: Reduces androgen‑driven acne when prescribed for dermatologic indications. - Endometriosis symptom relief: Alleviates dysmenorrhea associated with endometriosis.

Leverette may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset, especially when starting therapy. - Headache: transient tension‑type headaches. - Breast tenderness: mild swelling or discomfort. - Irregular bleeding: spotting or breakthrough bleeding. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins, requiring immediate medical attention. - Pulmonary embolism: blockage of lung arteries, a life‑threatening emergency. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: abnormal liver enzymes or jaundice. - Stroke: rare cerebrovascular event. - Severe hypertension: sudden increase in blood pressure.

Before prescribing Leverette, clinicians should evaluate several safety considerations. - Medical history assessment: review personal or family history of thromboembolic disorders. - Cardiovascular risk: avoid use in patients with uncontrolled hypertension or smoking over age 35. - Liver function: assess hepatic disease before initiation. - Medication review: consider interactions with enzyme‑inducing drugs. - Pregnancy status: confirm non‑pregnant state prior to starting therapy. - Store at ambient temperature: keep tablets below 25 °C in original packaging, protected from moisture.

Leverette can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin and other strong CYP3A4 inducers: may lead to contraceptive failure.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: may slightly decrease hormone levels. - Antifungal azoles (e.g., ketoconazole): may increase hormone concentrations, raising side‑effect risk. - St. John’s wort: can lower contraceptive effectiveness.